Fundraising Fox
/Companies
Sign in

DurVena

Mission, US · Founded 2020 · Delaware corporation

Find your way into DurVena

Sign up to see every warm intro you have to DurVena

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the DurVena team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

DurVena is developing a photochemical tissue passivation therapy that treats harvested veins to strengthen tissue and improve long-term vein graft durability. The company targets vascular surgery applications where vein grafts are used for reconstructive procedures.

BiotechHealthtechMedical Devices

Founders & leadership

ESEric Schlote
Eric SchloteChief Executive Officer

Board

RT
Robert ThatcherBoard director
WA
William AustenBoard director

Reported raises · per SEC filings

Form D private placements

$14M disclosed across 1 round · 2024

▶$14MraisedJan 2025 · 37 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert ThatcherDirector
  • Eric SchloteExecutive Officer, Director
  • William AustenDirector
Offering amount
$16.2M
Amount sold
$14M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Intervene IncInterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions. Its technology targets venous disease conditions such as postthrombotic syndrome that current therapies fail to address.

Companies working in the same space as DurVena.

Frequently asked questions

What does DurVena do?
DurVena is developing a photochemical tissue passivation therapy that treats harvested veins to strengthen tissue and improve long-term vein graft durability. The company targets vascular surgery applications where vein grafts are used for reconstructive procedures.
How much funding has DurVena raised?
DurVena has disclosed $14M raised across 1 round.
Where is DurVena headquartered?
DurVena is headquartered in Mission, US.